IRC
CABA icon

Investors Research Corp’s Cabaletta Bio CABA Stock Holding History

Investors Research Corp’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150
Closed -$1.39K – 1132
2022
Q4 		$1.39K Buy
150
+84
+127% +$306 ﹤0.01% 1021
2022
Q3 		$0 Hold
66
– – ﹤0.01% 1092
2022
Q2 		$0 Hold
66
– – ﹤0.01% 1089
2022
Q1 		$0 Hold
66
– – ﹤0.01% 1028
2021
Q4 		$0 Hold
66
– – ﹤0.01% 991
2021
Q3 		$1K Hold
66
– – ﹤0.01% 939
2021
Q2 		$1K Hold
66
– – ﹤0.01% 925
2021
Q1 		$1K Sell
66
-10
-13% -$122 ﹤0.01% 919
2020
Q4 		$1K Hold
76
– – ﹤0.01% 1019
2020
Q3 		$1K Buy
+76
New +$874 ﹤0.01% 1028

Other funds holding CABA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Investors Research Corp's CABA Position: Q1 2023 in Review

Investors Research Corp sold out of Cabaletta Bio (CABA) in Q1 2023, closing a stake of 150 shares — an estimated $1.39K sold.

Investors Research Corp first reported a position in CABA in Q3 2020 and held it in 10 quarters. The position peaked at $1.39K in Q4 2022. 71 funds tracked by Wall St. Rank hold CABA as of Q1 2023.

  • Investors Research Corp reported no remaining Cabaletta Bio position as of Q1 2023 after selling out during the quarter.
  • Investors Research Corp sold 150 Cabaletta Bio shares in Q1 2023, an estimated $1.39K.
  • Investors Research Corp first reported a position in Cabaletta Bio in Q3 2020 and held it in 10 quarters.
  • Investors Research Corp's Cabaletta Bio position peaked at $1.39K in Q4 2022.
  • 71 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2023.

Based on Investors Research Corp's 13F filing for Q1 2023, filed 11 May 2023.